At this time, posts about Isu Abxis are rapidly increasing on portals and securities communities. Today, foreigners have net sold 4,728 shares of Isu Abxis, while institutions have net bought 23,000 shares, according to provisional data. Isu Abxis, an affiliate of the Isu Group, is known as a company that develops antibiotic treatments and provides medical services.
As of 1:30 PM on the 5th, the stock price of Isu Abxis is 10,300 KRW, up 0.49% from the previous day, with a trading volume of 12,537,633 shares, which is 231.6% of the average trading volume on the 5th. On February 23, Isu Abxis was a market issue with the headline "Rising trend due to agreement to produce Russian COVID-19 vaccine."
In addition to Isu Abxis, posts by investors are also surging for Woongjin (016880), Sunic Systems (171090), and Daeyoung Packaging (014160).
※Source: AI Investment Assistant AI Lasso
※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
